Facilities Maintenance Engineer

Req ID:  106195
Location: 

Saffron Walden, GB, CB10 1XL Harlow, GB, CM19 5TR

For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.

Job Summary

We have an exciting opportunity for a hands-on, highly skilled Facilities Maintenance Engineer who will be responsible for ensuring all plant and equipment is maintained to the highest level as well as taking part in fault-finding activities and equipment upgrades across our two main sites - Saffron Walden and Harlow. 
You will be able to demonstrate a high degree of judgement and initiative to resolve issues, take the lead in upgrading the facility where necessary & ensures cost control, quality and completeness of work. 

 

Responsibilities include:
•    Responsibility for maintaining the building, fixtures and fittings, plant, equipment and services in an efficient, safe manner to support a multidisciplinary drug discovery laboratory facility.
•    The majority of your daily duties will involve general hands-on building, plant maintenance and engineering tasks 
•    Ensuring that facilities function as required, e.g. HVAC, laboratory air input (Air Handling Units) and air extract systems, services such as hot and cold-water supplies, ducted air supply and associated components such as dampers and actuators, drive belts and filter changes etc. 
•    Planning and carrying out preventative maintenance in order to ensure a high standard of plant maintenance is achieved at all times
•    Looking for and implementing continuous improvements both individually and as part of a team
•    Interacting with internal stakeholders, service contracts and service providers’ engineers to minimise disruption caused by servicing and breakdowns.  By ensuring that whilst on site contractors work safely, comply with H&S policies and checking that work is carried out to specification. Liaising with budget holders/departments to consider planned replacement of old equipment or changes in equipment numbers.
•    Issuing guidelines to managers and staff where applicable and liaising with Park security staff and outside agencies to ensure that the facilities comply with current legislation, e.g. The Health and Safety at Work etc. Act, The Workplace Health and Safety Regulations 1992 and other relevant legislation.  
•    To assist with internal moves and relocations

 

Requirements:
•    A strong track record in a similar role, ideally within a laboratory environment
•    NVQ or G.E.D level education in Electrical Engineering, Mechanical Engineering, or Building Services. (An equivalent combination of education and experience may be accepted as a satisfactory substitute for the specific education and experience listed above)
•    Able to assess and design electrical or mechanical systems
•    Demonstrable track record of planning and implementing preventative and corrective maintenance procedures
•    Able to fault find confidently in mechanical and electrical systems
•    Knowledge of building infrastructure
•    Comfortable owning and delivering on projects
•    Able to work in a fast-paced environment
•    Analytical and able to confidently solve problems
•    Organised and meticulous with a strong attention to detail
•    Excellent communication skills (both written and verbal)
•    IT literate with experience of Word, Excel and BMS (Building Management Systems)
•    Some out of hours emergency cover will be required on a rota basis
 

About Discovery
Discovery from Charles River is industry-proven in the successful development of novel therapies, with over 350 patents and 80 preclinical drug candidates delivered to our sponsors in the past 17 years. Backed by more than 650 scientists, our comprehensive, integrated portfolio employs the latest technology and platforms to provide chemistry, biology, and pharmacology services that support clients from the earliest stages of hit identification all the way through to IND. Our client-focused, collaborative approach creates true partnerships that anticipate challenges, overcome obstacles, and move us forward together on the journey of getting new drugs to market.

 

About Charles River
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.

 

With over 17,000 employees within 90 facilities in 20 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2019, revenue increased to $2.62 billion.

 

At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of ~85% of the drugs approved by the FDA in 2019.